Fred Restaino, based in United States, is currently a Sr. Director Clinical Supply Chain at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company. Fred Restaino brings experience from previous roles at POINT Biopharma, Taysha Gene Therapies, Clinical Supply Management, Inc. and Gilead Sciences. Fred Restaino holds a B.S in Pharmacy @ Philadelphia College of Pharmacy & Science. With a robust skill set that includes IND, Sop, FDA, Pharmacology, Pharmacovigilance and more. Fred Restaino has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Fred Restaino?
Find contact details for 700 million professionals.